trial · primary record
carboplatin
Inflammatory Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 67 |
| Primary completion | 2026-11-11 |
| Primary endpoint | pCR Rate After Treatment. |
| Registry ID | NCT01525966 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:34.327Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01525966
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- CARBOPLATIN · approval
- Carboplatin · compound